Clinical Trial Page

Clinical Trial Results:
A multi-national, multi-centre, randomized, parallel-group, double-blind study to compare the efficacy, tolerability and safety of Glatiramer Acetate Injection 40 mg/ml to that of Glatiramer Acetate Injection 20 mg/ml administered once daily by subcutaneous injection in subjects with relapsing remitting (RR) Multiple Sclerosis (MS)

Summary
EudraCT number
2006-002037-20
Trial protocol
HU   FI   ES   BE   GB   LV   CZ   IT   LT   DE   EE  
Global completion date
19 Nov 2008

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?
No

Results information
Results version number
v1(current)
This version publication date
28 Dec 2016
First version publication date
28 Dec 2016
Other versions
Summary report(s)
GA-9016
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.
3